UK Eyelash Pioneers Plan to Launch Service to Target Baldness

Share Article

A treatment used for growing eyelashes is currently being researched for the treatment of scalp balding. Mylash, who were the first company in the UK to prescribe eyelash growth drugs, plan to offer prescription baldness treatment using the same drug in the future.

The product used for growing eyelashes, is currently being researched for the treatment of scalp balding.

Eyelash growth pioneers have helped thousands of people in Britain and across Europe grow their eyelashes longer, thicker and darker.

The active ingredient of the treatment is a prostamide. This compound acts on prostaglandin receptors which control the hair cycle, acting to increase the amount of resources dedicated to growth and increase the length of each cycle. The result is a hair with a stronger root and thicker shaft. The increased thickness of the shaft provides more support which allows for a longer hair to be supported.

When clinical trials were carried out by the American FDA on the compound they found that the average healthy trial participant grew eyelashes that were 25% longer, 106% thicker and 18% darker. Trials have also been carried out on patients after chemotherapy and the drug was found to significantly improve the regrowth of the patients eyelashes.

Although scalp hair follicles and eyelash follicles are not identical it is not unreasonable to suggest that an effective hair stimulant that acts on one type of hair should act on another type. The experimental studies mentioned support the stimulating effects of prostaglandin analouges on hairs other than eyelashes.

Male parttern baldness, also known as androgenetic alopecia, is the most common cause of hair loss in both men and women. It is estimated that 70% of men and 40% of women will experience a degree of hair loss that could be attributed to male pattern baldness in their lifetime. It can be a psychologically and emotionally challenging experience for anyone experiencing the problem.

Studies conducted on scalp hair follicles have found that prostaglandin receptor expression is increased before and during the growth phase of the hair cycle. A group of Swedish dermatologists carried out a study which looked at the use of a prostaglandin analogue on monkeys displaying male pattern baldness and found a significant effect on hair regrowth, and another study using a prostaglandin agonist showed a positive regrowth of mice fur.

Minoxidil, which is currently available over the counter in Britain as Rogaine, is used as treatment for male pattern baldness. The mode of action for hair growth has not been conclusively understood but recent papers have shown that it increases prostaglandin synthesis in the applied areas. This suggests that a prostaglandin analogue would provide more direct and therefore better results.

A study that was published in May 2012 in the Journal of American Academy of Dermatology used a topical prostaglandin for the treatment of mild male pattern baldness with 16 healthy men. They found that there was a significant increase in scalp hair density and concluded that it could be an effective treatment for stimulating hair follicle activity and treating hair loss.

Mylash, the market leader for eyelash growth consultations, is planning to offer a prostaglandin based treatment to the UK market in 2013.

Mylash has treated thousands of clients within the UK. We have celebrity followers and have been featured in many British publications including Grazia, the Daily Mail, the London Evening Standard, Hello magazine, Elle and more. We have a team of British medical doctors and keep patient safety at the core of our business.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tom Walker
Email >
Follow us on
Visit website


MylashLatisse UK pressLatisse before and after